ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,965.42
0.35%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Fusion Pharmaceuticals Inc (FUSN) Share Price

FUSN Fusion Pharmaceuticals Inc

21.52
0.05 (0.23%)
31 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Fusion Pharmaceuticals Inc NASDAQ:FUSN NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.05 0.23 21.52 21.53 21.57 21.60 21.46 21.5 952,407 21:25:24   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 2.07M -94.9M -1.3755 -15.65 1.49B
 Type  Size  Price  Time  Units 
 9 50 21.5693 23:27:48 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore FUSN News
31/05/202421:12EDGAR2Form 8-K - Current report
31/05/202421:05PRNUSFusion Pharmaceuticals Receives Final Court Order Approving Arrangement
31/05/202421:05PRNCAFusion Pharmaceuticals Receives Final Court Order Approving Arrangement
29/05/202421:34EDGAR2Form 8-K - Current report
29/05/202421:05PRNCAFusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
29/05/202421:05PRNUSFusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
10/05/202421:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Period
Draw mode
Data Downloads for FUSN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Fusion Pharmaceuticals Inc Articles